

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.01447115 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.01447115 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.01447115 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.01447115 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.01447115 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.01447115 |
| 7 | response to muramyl dipeptide (GO:0032495) | 5.76943243 |
| 8 | modulation by symbiont of host cellular process (GO:0044068) | 5.69117691 |
| 9 | response to peptidoglycan (GO:0032494) | 5.45516198 |
| 10 | cellular extravasation (GO:0045123) | 5.06800704 |
| 11 | neutrophil mediated immunity (GO:0002446) | 4.92338180 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.90465225 |
| 13 | positive regulation of heat generation (GO:0031652) | 4.79748348 |
| 14 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.73311794 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.69072769 |
| 16 | cell adhesion mediated by integrin (GO:0033627) | 4.68422685 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.66104608 |
| 18 | germinal center formation (GO:0002467) | 4.63451104 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 4.62758397 |
| 20 | response to host immune response (GO:0052572) | 4.54080791 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.54080791 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.49076766 |
| 23 | natural killer cell mediated immunity (GO:0002228) | 4.17616547 |
| 24 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.17616547 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.14382951 |
| 26 | response to host (GO:0075136) | 4.14382951 |
| 27 | response to host defenses (GO:0052200) | 4.14382951 |
| 28 | microglial cell activation (GO:0001774) | 4.13382045 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.13073402 |
| 30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.11784143 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.11061551 |
| 32 | detection of other organism (GO:0098543) | 4.09265788 |
| 33 | I-kappaB phosphorylation (GO:0007252) | 4.05474226 |
| 34 | negative regulation of lipid storage (GO:0010888) | 4.01092156 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.87030500 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.85564138 |
| 37 | regulation of fever generation (GO:0031620) | 3.82452467 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77543716 |
| 39 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.75274681 |
| 40 | macroautophagy (GO:0016236) | 3.73750747 |
| 41 | modulation by virus of host process (GO:0019054) | 3.73561656 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.73364405 |
| 43 | wound healing, spreading of epidermal cells (GO:0035313) | 3.69727954 |
| 44 | myeloid leukocyte mediated immunity (GO:0002444) | 3.68101555 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63351534 |
| 46 | regulation of heat generation (GO:0031650) | 3.61478602 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59928959 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.59807497 |
| 49 | developmental pigmentation (GO:0048066) | 3.59701439 |
| 50 | detection of bacterium (GO:0016045) | 3.58094251 |
| 51 | B cell homeostasis (GO:0001782) | 3.57388855 |
| 52 | regulation of interferon-alpha production (GO:0032647) | 3.56628055 |
| 53 | cellular response to virus (GO:0098586) | 3.54684580 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.54573535 |
| 55 | regulation of mast cell activation (GO:0033003) | 3.54178986 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.54024138 |
| 57 | regulation of integrin activation (GO:0033623) | 3.53357697 |
| 58 | modification by symbiont of host morphology or physiology (GO:0044003) | 3.51068282 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.50435554 |
| 60 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.50342703 |
| 61 | regulation of chronic inflammatory response (GO:0002676) | 3.45430478 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42674900 |
| 63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.40795289 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 3.40795289 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.40039091 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36239674 |
| 67 | respiratory burst (GO:0045730) | 3.31217773 |
| 68 | positive regulation of protein homooligomerization (GO:0032464) | 3.28616687 |
| 69 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.28356909 |
| 70 | leukocyte mediated cytotoxicity (GO:0001909) | 3.26138396 |
| 71 | neutrophil chemotaxis (GO:0030593) | 3.25945310 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25787843 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24653180 |
| 74 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.24167967 |
| 75 | negative regulation of cell killing (GO:0031342) | 3.24151249 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.24151249 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22929868 |
| 78 | leukocyte aggregation (GO:0070486) | 3.20856878 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.20597283 |
| 80 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.20447289 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19262055 |
| 82 | macrophage activation (GO:0042116) | 3.19074447 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.18597213 |
| 84 | positive regulation of humoral immune response (GO:0002922) | 3.18462233 |
| 85 | granulocyte activation (GO:0036230) | 3.18392733 |
| 86 | positive regulation of p38MAPK cascade (GO:1900745) | 3.17623437 |
| 87 | neutrophil migration (GO:1990266) | 3.17622210 |
| 88 | response to protozoan (GO:0001562) | 3.17471832 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14573089 |
| 90 | neutrophil activation (GO:0042119) | 3.14017674 |
| 91 | positive regulation of B cell differentiation (GO:0045579) | 3.13595959 |
| 92 | T-helper 1 type immune response (GO:0042088) | 3.13159508 |
| 93 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.12501755 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12010106 |
| 95 | leukocyte cell-cell adhesion (GO:0007159) | 3.09950665 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.09854070 |
| 97 | * detection of biotic stimulus (GO:0009595) | 3.08596409 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 3.08276611 |
| 99 | detection of molecule of bacterial origin (GO:0032490) | 3.07681343 |
| 100 | regulation of mast cell degranulation (GO:0043304) | 3.06313073 |
| 101 | negative regulation of interleukin-17 production (GO:0032700) | 3.06174867 |
| 102 | positive regulation of type 2 immune response (GO:0002830) | 3.05439055 |
| 103 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.03421813 |
| 104 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02931831 |
| 105 | positive regulation of interleukin-2 production (GO:0032743) | 3.00763338 |
| 106 | regulation of interleukin-17 production (GO:0032660) | 3.00017361 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99674521 |
| 108 | pinocytosis (GO:0006907) | 2.99600731 |
| 109 | immunoglobulin mediated immune response (GO:0016064) | 2.98572470 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97888890 |
| 111 | regulation of podosome assembly (GO:0071801) | 2.97558423 |
| 112 | positive regulation of interferon-beta production (GO:0032728) | 2.97324494 |
| 113 | positive regulation of interleukin-12 production (GO:0032735) | 2.96511675 |
| 114 | apoptotic cell clearance (GO:0043277) | 2.96209048 |
| 115 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.96153044 |
| 116 | negative regulation of growth of symbiont in host (GO:0044130) | 2.95696720 |
| 117 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.95696720 |
| 118 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.95696720 |
| 119 | regulation of growth of symbiont in host (GO:0044126) | 2.95696720 |
| 120 | positive regulation of interleukin-6 production (GO:0032755) | 2.95583876 |
| 121 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.95327940 |
| 122 | regulation of alkaline phosphatase activity (GO:0010692) | 2.94564280 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94550787 |
| 124 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94238219 |
| 125 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.93434364 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.92318869 |
| 127 | B cell mediated immunity (GO:0019724) | 2.91086495 |
| 128 | positive regulation of acute inflammatory response (GO:0002675) | 2.90530803 |
| 129 | myeloid cell homeostasis (GO:0002262) | 2.90353048 |
| 130 | regulation of antigen processing and presentation (GO:0002577) | 2.89135830 |
| 131 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88501291 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.88458553 |
| 133 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88388091 |
| 134 | leukocyte degranulation (GO:0043299) | 2.87762392 |
| 135 | regulation of interleukin-6 production (GO:0032675) | 2.87563806 |
| 136 | virion attachment to host cell (GO:0019062) | 2.86557754 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 2.86557754 |
| 138 | regulation of mononuclear cell migration (GO:0071675) | 2.83328759 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 2.81483444 |
| 140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79024634 |
| 141 | regulation of interleukin-12 production (GO:0032655) | 2.78228396 |
| 142 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.77196302 |
| 143 | superoxide anion generation (GO:0042554) | 2.73595375 |
| 144 | defense response to protozoan (GO:0042832) | 2.73321114 |
| 145 | reactive oxygen species biosynthetic process (GO:1903409) | 2.72945513 |
| 146 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.72937620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.28352382 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94549497 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.66803358 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.57833775 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.54661575 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.00878944 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.71285469 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56803832 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.43970221 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.41351260 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.34261132 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26175747 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.11159904 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89145554 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63336198 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60696510 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54145896 |
| 18 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.52205993 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33611471 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30975389 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.25769197 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16670474 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13405514 |
| 24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.11507690 |
| 25 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.06377435 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98920618 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88230497 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87606092 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87339010 |
| 30 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.85931604 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82793846 |
| 32 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.80477066 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75307271 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75261333 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.73833743 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68845980 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67698558 |
| 38 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.67317947 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59735767 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57917141 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54825743 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50233166 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43107949 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42946961 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42816839 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42352471 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.40123656 |
| 48 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39103445 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38168089 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36467832 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.36158977 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31493958 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27038824 |
| 54 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26460013 |
| 55 | * MYB_26560356_Chip-Seq_TH2_Human | 1.25693870 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25621783 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25551672 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.24809116 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21005005 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16873051 |
| 61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16504898 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16401410 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13700664 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13016199 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12845445 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11196640 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09098848 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07226794 |
| 69 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.05895694 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04599112 |
| 71 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03722549 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03704027 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03538557 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02782337 |
| 75 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01634146 |
| 76 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01247857 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01073559 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00952942 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99880878 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98546210 |
| 81 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98478450 |
| 82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98478450 |
| 83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98478450 |
| 84 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98315635 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98110451 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97336893 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96164910 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95736153 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95356520 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94917502 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94134021 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91973006 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91774025 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91419083 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90358845 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90358845 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90026938 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88583068 |
| 99 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87361446 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87342838 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85703566 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85651762 |
| 103 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85181880 |
| 104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81718088 |
| 105 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.80960702 |
| 106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79955140 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78754627 |
| 108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78406538 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78293394 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78145675 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78143487 |
| 112 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76629464 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76555028 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.76356378 |
| 115 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75381676 |
| 116 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75032281 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74894589 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.72770776 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72685142 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71867353 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71867353 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.70245942 |
| 123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69129989 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.66812495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.95634451 |
| 2 | MP0003303_peritoneal_inflammation | 3.73716169 |
| 3 | MP0003436_decreased_susceptibility_to | 3.31144549 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.25917247 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.25143169 |
| 6 | MP0004510_myositis | 3.06957025 |
| 7 | * MP0002419_abnormal_innate_immunity | 2.98009466 |
| 8 | MP0009785_altered_susceptibility_to | 2.76980927 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.76352866 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.57569992 |
| 11 | * MP0005000_abnormal_immune_tolerance | 2.46238794 |
| 12 | MP0005387_immune_system_phenotype | 2.45947980 |
| 13 | MP0001790_abnormal_immune_system | 2.45947980 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.43620149 |
| 15 | * MP0001835_abnormal_antigen_presentation | 2.42610479 |
| 16 | MP0001800_abnormal_humoral_immune | 2.40811995 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.40385614 |
| 18 | * MP0005025_abnormal_response_to | 2.38206018 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.36144787 |
| 20 | MP0000685_abnormal_immune_system | 2.36080768 |
| 21 | * MP0002723_abnormal_immune_serum | 2.23317757 |
| 22 | * MP0004947_skin_inflammation | 2.13626839 |
| 23 | MP0006082_CNS_inflammation | 2.12766834 |
| 24 | MP0000015_abnormal_ear_pigmentation | 2.11055681 |
| 25 | MP0008004_abnormal_stomach_pH | 2.00454138 |
| 26 | MP0003724_increased_susceptibility_to | 1.99907595 |
| 27 | MP0009840_abnormal_foam_cell | 1.94268696 |
| 28 | MP0003448_altered_tumor_morphology | 1.93052682 |
| 29 | * MP0001819_abnormal_immune_cell | 1.91459508 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 1.89136501 |
| 31 | * MP0002148_abnormal_hypersensitivity_rea | 1.85229192 |
| 32 | MP0005671_abnormal_response_to | 1.75838951 |
| 33 | MP0000604_amyloidosis | 1.73763446 |
| 34 | MP0002254_reproductive_system_inflammat | 1.72034141 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.71693715 |
| 36 | MP0002405_respiratory_system_inflammati | 1.67836852 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.65555645 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.55962393 |
| 39 | MP0008260_abnormal_autophagy | 1.55523164 |
| 40 | MP0000371_diluted_coat_color | 1.52956424 |
| 41 | * MP0001845_abnormal_inflammatory_respons | 1.52324029 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.51974726 |
| 43 | MP0002009_preneoplasia | 1.50553784 |
| 44 | MP0001853_heart_inflammation | 1.48770324 |
| 45 | * MP0009278_abnormal_bone_marrow | 1.48538383 |
| 46 | MP0009764_decreased_sensitivity_to | 1.46438039 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.43190040 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.43090037 |
| 49 | * MP0008469_abnormal_protein_level | 1.36302393 |
| 50 | MP0000343_altered_response_to | 1.36139329 |
| 51 | MP0003075_altered_response_to | 1.31962245 |
| 52 | * MP0000716_abnormal_immune_system | 1.28334198 |
| 53 | MP0001851_eye_inflammation | 1.27974040 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.26582396 |
| 55 | * MP0002398_abnormal_bone_marrow | 1.26012510 |
| 56 | MP0002006_tumorigenesis | 1.25351630 |
| 57 | MP0000858_altered_metastatic_potential | 1.24585323 |
| 58 | MP0003091_abnormal_cell_migration | 1.19307041 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.18760110 |
| 60 | * MP0000689_abnormal_spleen_morphology | 1.17644119 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.17569152 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.15903207 |
| 63 | MP0001958_emphysema | 1.15637039 |
| 64 | MP0002132_abnormal_respiratory_system | 1.14952234 |
| 65 | MP0010307_abnormal_tumor_latency | 1.13033550 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.12978406 |
| 67 | MP0004883_abnormal_blood_vessel | 1.09591908 |
| 68 | * MP0001545_abnormal_hematopoietic_system | 1.06809788 |
| 69 | * MP0005397_hematopoietic_system_phenotyp | 1.06809788 |
| 70 | MP0003828_pulmonary_edema | 1.06439131 |
| 71 | MP0005451_abnormal_body_composition | 1.05872344 |
| 72 | * MP0002429_abnormal_blood_cell | 1.00580691 |
| 73 | MP0003866_abnormal_defecation | 0.99950656 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.98657023 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.97424012 |
| 76 | * MP0002722_abnormal_immune_system | 0.97405928 |
| 77 | * MP0009763_increased_sensitivity_to | 0.95836471 |
| 78 | MP0003690_abnormal_glial_cell | 0.94062109 |
| 79 | MP0001873_stomach_inflammation | 0.91697458 |
| 80 | MP0004858_abnormal_nervous_system | 0.91090060 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.90964925 |
| 82 | MP0004381_abnormal_hair_follicle | 0.88179116 |
| 83 | MP0005023_abnormal_wound_healing | 0.86190741 |
| 84 | MP0002933_joint_inflammation | 0.83799594 |
| 85 | MP0001663_abnormal_digestive_system | 0.81401126 |
| 86 | MP0005164_abnormal_response_to | 0.80218062 |
| 87 | MP0000249_abnormal_blood_vessel | 0.79880171 |
| 88 | MP0006054_spinal_hemorrhage | 0.79633150 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.78695471 |
| 90 | MP0005166_decreased_susceptibility_to | 0.77434509 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.77365983 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.77278085 |
| 93 | MP0005310_abnormal_salivary_gland | 0.76730054 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.76549912 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.76443039 |
| 96 | MP0005390_skeleton_phenotype | 0.75569850 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.74743802 |
| 98 | MP0005197_abnormal_uvea_morphology | 0.74070636 |
| 99 | MP0003045_fibrosis | 0.74056956 |
| 100 | MP0005621_abnormal_cell_physiology | 0.73961805 |
| 101 | MP0005535_abnormal_body_temperature | 0.73665381 |
| 102 | MP0004484_altered_response_of | 0.72045065 |
| 103 | MP0005083_abnormal_biliary_tract | 0.69073472 |
| 104 | MP0001191_abnormal_skin_condition | 0.67417607 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.67173986 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.66088456 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.66052295 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.66038600 |
| 109 | MP0000383_abnormal_hair_follicle | 0.65900875 |
| 110 | MP0003795_abnormal_bone_structure | 0.65067438 |
| 111 | MP0002928_abnormal_bile_duct | 0.64340687 |
| 112 | MP0000920_abnormal_myelination | 0.64251242 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.64136447 |
| 114 | MP0001243_abnormal_dermal_layer | 0.63819259 |
| 115 | MP0005647_abnormal_sex_gland | 0.63701881 |
| 116 | MP0002075_abnormal_coat/hair_pigmentati | 0.63146872 |
| 117 | MP0005165_increased_susceptibility_to | 0.63116678 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.62163250 |
| 119 | MP0003195_calcinosis | 0.54005194 |
| 120 | MP0008874_decreased_physiological_sensi | 0.51721675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.62508193 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.35838764 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.72352684 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.97124466 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.90145991 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.81795802 |
| 7 | Prostate neoplasm (HP:0100787) | 4.47959401 |
| 8 | Thick nail (HP:0001805) | 4.47469445 |
| 9 | Gingivitis (HP:0000230) | 4.44357780 |
| 10 | Optic neuritis (HP:0100653) | 4.41081816 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.41081816 |
| 12 | Orchitis (HP:0100796) | 4.26020707 |
| 13 | Recurrent skin infections (HP:0001581) | 4.24286123 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.20996256 |
| 15 | Myositis (HP:0100614) | 3.95274987 |
| 16 | Periodontitis (HP:0000704) | 3.92553805 |
| 17 | Hematochezia (HP:0002573) | 3.89635510 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86495672 |
| 19 | Submucous cleft hard palate (HP:0000176) | 3.46927202 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.40287919 |
| 21 | Pustule (HP:0200039) | 3.31164252 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.30039064 |
| 23 | Encephalitis (HP:0002383) | 3.27814478 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.27281012 |
| 25 | Gangrene (HP:0100758) | 3.20406637 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.20349315 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17382827 |
| 28 | Turricephaly (HP:0000262) | 3.10591014 |
| 29 | Premature loss of primary teeth (HP:0006323) | 3.09973394 |
| 30 | Loss of speech (HP:0002371) | 2.96444063 |
| 31 | Obstructive lung disease (HP:0006536) | 2.94498502 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94498502 |
| 33 | Urethral obstruction (HP:0000796) | 2.91003772 |
| 34 | Large earlobe (HP:0009748) | 2.89778065 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.87919322 |
| 36 | * Amyloidosis (HP:0011034) | 2.87838073 |
| 37 | Increased IgE level (HP:0003212) | 2.87138422 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83761283 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83761283 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83761283 |
| 41 | Chest pain (HP:0100749) | 2.80101935 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.77072306 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.76651265 |
| 44 | Increased serum ferritin (HP:0003281) | 2.76648370 |
| 45 | Axonal loss (HP:0003447) | 2.76631744 |
| 46 | Pulmonary artery stenosis (HP:0004415) | 2.71992529 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71930794 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.67151628 |
| 49 | T lymphocytopenia (HP:0005403) | 2.66758546 |
| 50 | Gingival bleeding (HP:0000225) | 2.66455060 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.62264404 |
| 52 | Long toe (HP:0010511) | 2.60410545 |
| 53 | Frequent falls (HP:0002359) | 2.60173317 |
| 54 | Recurrent viral infections (HP:0004429) | 2.58683379 |
| 55 | * Vasculitis (HP:0002633) | 2.58144385 |
| 56 | Osteomyelitis (HP:0002754) | 2.57185293 |
| 57 | Pulmonary embolism (HP:0002204) | 2.56939566 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.54328647 |
| 59 | Tetraparesis (HP:0002273) | 2.54310395 |
| 60 | Colitis (HP:0002583) | 2.51156617 |
| 61 | Anorexia (HP:0002039) | 2.50727507 |
| 62 | * Stomatitis (HP:0010280) | 2.49042541 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.48889131 |
| 64 | Vertigo (HP:0002321) | 2.48268771 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46808105 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46808105 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.45159163 |
| 68 | Myocardial infarction (HP:0001658) | 2.44227937 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.42098053 |
| 70 | Bone pain (HP:0002653) | 2.40916352 |
| 71 | Cellulitis (HP:0100658) | 2.39130419 |
| 72 | Amaurosis fugax (HP:0100576) | 2.38613861 |
| 73 | Fatigue (HP:0012378) | 2.38202329 |
| 74 | Arterial thrombosis (HP:0004420) | 2.37877473 |
| 75 | Thrombocytosis (HP:0001894) | 2.37687213 |
| 76 | Petechiae (HP:0000967) | 2.37467836 |
| 77 | Absent frontal sinuses (HP:0002688) | 2.32298123 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.32231698 |
| 79 | * Episodic fever (HP:0001954) | 2.27057537 |
| 80 | Eosinophilia (HP:0001880) | 2.26330261 |
| 81 | Hypophosphatemia (HP:0002148) | 2.23667599 |
| 82 | Abnormality of T cells (HP:0002843) | 2.23467597 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.21897641 |
| 84 | * Polyneuropathy (HP:0001271) | 2.21535464 |
| 85 | Glomerulopathy (HP:0100820) | 2.18840611 |
| 86 | Increased IgM level (HP:0003496) | 2.17626346 |
| 87 | Abnormality of the endocardium (HP:0004306) | 2.17169186 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.16279726 |
| 89 | Glomerulonephritis (HP:0000099) | 2.16198547 |
| 90 | Abnormality of the prostate (HP:0008775) | 2.15826522 |
| 91 | Pathologic fracture (HP:0002756) | 2.14698329 |
| 92 | Abnormality of the columella (HP:0009929) | 2.14558686 |
| 93 | * Leukocytosis (HP:0001974) | 2.13462559 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.13035535 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.11764614 |
| 96 | Purpura (HP:0000979) | 2.10210740 |
| 97 | Dysostosis multiplex (HP:0000943) | 2.09623408 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.09512561 |
| 99 | Generalized hypopigmentation (HP:0007513) | 2.08842503 |
| 100 | Disinhibition (HP:0000734) | 2.08832300 |
| 101 | Keratitis (HP:0000491) | 2.08739091 |
| 102 | Sepsis (HP:0100806) | 2.07928252 |
| 103 | Meningitis (HP:0001287) | 2.06298426 |
| 104 | Joint swelling (HP:0001386) | 2.03089400 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02222209 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02222209 |
| 107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02222209 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 2.01437031 |
| 109 | Hemoptysis (HP:0002105) | 2.01210666 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 1.98193828 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98193828 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 1.97454517 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.95640761 |
| 114 | Thrombophlebitis (HP:0004418) | 1.94688277 |
| 115 | Distal lower limb amyotrophy (HP:0008944) | 1.94672771 |
| 116 | Neurodegeneration (HP:0002180) | 1.92637572 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92554822 |
| 118 | Joint hemorrhage (HP:0005261) | 1.92487938 |
| 119 | Peripheral demyelination (HP:0011096) | 1.92247140 |
| 120 | Mutism (HP:0002300) | 1.91906264 |
| 121 | Epistaxis (HP:0000421) | 1.91896479 |
| 122 | Inflammation of the large intestine (HP:0002037) | 1.91623257 |
| 123 | Natal tooth (HP:0000695) | 1.91485685 |
| 124 | Esophageal neoplasm (HP:0100751) | 1.90754887 |
| 125 | Neoplasm of head and neck (HP:0012288) | 1.90754887 |
| 126 | Nausea (HP:0002018) | 1.90535386 |
| 127 | Spondylolisthesis (HP:0003302) | 1.90371725 |
| 128 | Alveolar cell carcinoma (HP:0006519) | 1.90062301 |
| 129 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90005647 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.89261042 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.87977005 |
| 132 | Abnormality of the frontal sinuses (HP:0002687) | 1.86395644 |
| 133 | Bruising susceptibility (HP:0000978) | 1.85419028 |
| 134 | Impaired platelet aggregation (HP:0003540) | 1.84817930 |
| 135 | Abnormal platelet function (HP:0011869) | 1.84817930 |
| 136 | Protruding tongue (HP:0010808) | 1.83685468 |
| 137 | Albinism (HP:0001022) | 1.81219423 |
| 138 | Leukopenia (HP:0001882) | 1.81106007 |
| 139 | * Urticaria (HP:0001025) | 1.77022654 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.76860650 |
| 141 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76860650 |
| 142 | Ocular albinism (HP:0001107) | 1.74576845 |
| 143 | Granulocytopenia (HP:0001913) | 1.73217680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.34183288 |
| 2 | IRAK3 | 4.81608959 |
| 3 | RIPK4 | 4.15454355 |
| 4 | TBK1 | 3.66758128 |
| 5 | IRAK4 | 3.29644775 |
| 6 | IKBKE | 3.01685835 |
| 7 | TYK2 | 2.78336261 |
| 8 | TAOK3 | 2.53218485 |
| 9 | MAP3K13 | 2.53147190 |
| 10 | PRPF4B | 2.48193477 |
| 11 | IKBKB | 2.47514748 |
| 12 | MAP4K1 | 2.32670708 |
| 13 | KIT | 2.20810569 |
| 14 | CDK12 | 2.03375845 |
| 15 | CHUK | 1.96709784 |
| 16 | TXK | 1.93778159 |
| 17 | SIK2 | 1.89068745 |
| 18 | TTN | 1.79280836 |
| 19 | IRAK1 | 1.78763556 |
| 20 | JAK3 | 1.78357675 |
| 21 | IRAK2 | 1.75732066 |
| 22 | JAK1 | 1.75247075 |
| 23 | DAPK2 | 1.73689969 |
| 24 | FGR | 1.59309163 |
| 25 | BLK | 1.58592244 |
| 26 | FES | 1.50215135 |
| 27 | PTK6 | 1.48123829 |
| 28 | GRK7 | 1.47401856 |
| 29 | MAP3K10 | 1.42544374 |
| 30 | CSF1R | 1.41756063 |
| 31 | HCK | 1.41329076 |
| 32 | TNK2 | 1.34811280 |
| 33 | ZAP70 | 1.31465913 |
| 34 | GRK6 | 1.28967346 |
| 35 | RPS6KA4 | 1.27530351 |
| 36 | MOS | 1.23957823 |
| 37 | MAP3K1 | 1.23044897 |
| 38 | CSK | 1.19354117 |
| 39 | CAMK1G | 1.14522276 |
| 40 | EPHB1 | 1.13621145 |
| 41 | PIK3CG | 1.09659104 |
| 42 | LCK | 1.08474862 |
| 43 | TGFBR2 | 1.07358832 |
| 44 | MARK3 | 1.06034544 |
| 45 | ERN1 | 1.05682628 |
| 46 | MAP3K11 | 1.05310348 |
| 47 | JAK2 | 1.03515026 |
| 48 | SYK | 1.03132192 |
| 49 | CAMK1D | 1.02174448 |
| 50 | PDK2 | 1.01301542 |
| 51 | PIM1 | 0.89804271 |
| 52 | EGFR | 0.89577466 |
| 53 | MAP2K3 | 0.85983565 |
| 54 | EIF2AK2 | 0.85068215 |
| 55 | CDK6 | 0.83937758 |
| 56 | LYN | 0.83248930 |
| 57 | MAP3K3 | 0.82170966 |
| 58 | DAPK3 | 0.74880968 |
| 59 | RIPK1 | 0.72165822 |
| 60 | PLK2 | 0.71411856 |
| 61 | STK10 | 0.69256055 |
| 62 | ERBB4 | 0.68806215 |
| 63 | SIK3 | 0.65972089 |
| 64 | NEK9 | 0.61898147 |
| 65 | ITK | 0.60978538 |
| 66 | PDGFRB | 0.60972645 |
| 67 | KSR2 | 0.60913139 |
| 68 | SGK1 | 0.59494970 |
| 69 | ABL1 | 0.59118872 |
| 70 | BTK | 0.59035653 |
| 71 | YES1 | 0.57941420 |
| 72 | MAP3K6 | 0.57908474 |
| 73 | CDC42BPA | 0.55441229 |
| 74 | MATK | 0.55220696 |
| 75 | PKN1 | 0.53522844 |
| 76 | TEC | 0.53208327 |
| 77 | ERBB2 | 0.52980724 |
| 78 | MAP3K5 | 0.51978727 |
| 79 | CLK1 | 0.51061051 |
| 80 | CAMKK2 | 0.50918168 |
| 81 | MARK2 | 0.50295409 |
| 82 | SGK3 | 0.48100639 |
| 83 | MAPK10 | 0.46163810 |
| 84 | FYN | 0.45883548 |
| 85 | SIK1 | 0.45364828 |
| 86 | TESK2 | 0.44240453 |
| 87 | GSK3A | 0.44192218 |
| 88 | DDR2 | 0.42965123 |
| 89 | SGK2 | 0.42064118 |
| 90 | RPS6KA6 | 0.42054126 |
| 91 | PRKCD | 0.41631007 |
| 92 | DAPK1 | 0.41580291 |
| 93 | ARAF | 0.41411981 |
| 94 | MAPK4 | 0.39870397 |
| 95 | PAK4 | 0.39399647 |
| 96 | MAP2K2 | 0.39270046 |
| 97 | MAPK7 | 0.39186950 |
| 98 | BMPR2 | 0.39006936 |
| 99 | RPS6KA2 | 0.38674618 |
| 100 | MAPKAPK2 | 0.37550383 |
| 101 | MELK | 0.37430970 |
| 102 | BMX | 0.36937453 |
| 103 | EPHA3 | 0.36415763 |
| 104 | PDK1 | 0.36393400 |
| 105 | PDPK1 | 0.35861051 |
| 106 | TRPM7 | 0.33895581 |
| 107 | ALK | 0.33281679 |
| 108 | RPS6KA1 | 0.33127816 |
| 109 | TAOK1 | 0.32947327 |
| 110 | TAOK2 | 0.32490619 |
| 111 | MAPK12 | 0.32213555 |
| 112 | PRKG2 | 0.31641858 |
| 113 | PIM2 | 0.31236718 |
| 114 | PRKCQ | 0.30741365 |
| 115 | BRD4 | 0.29959815 |
| 116 | INSR | 0.29935187 |
| 117 | CDK19 | 0.28943565 |
| 118 | MTOR | 0.28700579 |
| 119 | RPS6KC1 | 0.27750334 |
| 120 | RPS6KL1 | 0.27750334 |
| 121 | CAMK4 | 0.27035201 |
| 122 | ADRBK2 | 0.26542471 |
| 123 | HIPK2 | 0.26445927 |
| 124 | STK3 | 0.26051664 |
| 125 | ABL2 | 0.25837277 |
| 126 | PTK2 | 0.25629171 |
| 127 | MAP2K6 | 0.24997950 |
| 128 | PRKD2 | 0.24092599 |
| 129 | SRC | 0.23899619 |
| 130 | NME2 | 0.23541979 |
| 131 | STK24 | 0.23028629 |
| 132 | MAPK3 | 0.22280024 |
| 133 | MAP3K7 | 0.21009126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.11296386 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.88046941 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.76504380 |
| 4 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.69033695 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.61359650 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56644842 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.45004527 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.31032988 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.22739910 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14768058 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.11592154 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.08483497 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.94669437 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.91445335 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88458463 |
| 16 | * Pertussis_Homo sapiens_hsa05133 | 1.88149721 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85524482 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.84205576 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.75933301 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71780650 |
| 21 | * Influenza A_Homo sapiens_hsa05164 | 1.63637962 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62542824 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61927446 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61832394 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57613942 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.57029241 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52906229 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50629907 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.49212414 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46733700 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.45880883 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45510243 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.41376533 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35708790 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26878346 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26305091 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.26246332 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21497943 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19828033 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15131926 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14706687 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.13719452 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09477107 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08646325 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.07306514 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05964092 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05931689 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05306268 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03411384 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02608004 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.02569176 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98964881 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93963855 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92644270 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90303590 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90105697 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86939931 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84994082 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83391540 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82880947 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.80572347 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77097487 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.76543522 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75755370 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73687803 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72774368 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72495133 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72055062 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69919103 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68075261 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65978614 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64290644 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63686611 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.61636861 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60507824 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58764562 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56657433 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56233626 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54834714 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.54011038 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53973073 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53754731 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.53173696 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49688298 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47957270 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46627829 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46115660 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44795023 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44527167 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.44403185 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44357869 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41222455 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41081181 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40980987 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40412619 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40166304 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38191631 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37810759 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36038014 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34255653 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32173038 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31744978 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30552317 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29920749 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.29105385 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28952688 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25397525 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20021211 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17800448 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16149323 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15952119 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.15372283 |

